Abstract 463P
Background
T factor depends on consolidation diameter in lung adenocarcinoma. Adenocarcinoma with short consolidation diameter could be indicated for sublobar resection. However, measurement of consolidation diameter under lung window in 2D-CT could be problematic, as the outline is not clear. We evaluated the relationship between consolidation lesion under mediastinal window in 3D-CT and pathological invasiveness, and aimed to predict invasiveness using machine learning algorithm.
Methods
Ninety-five patients who underwent surgical resection of lung adenocarcinoma that is less than 20 mm in diameter and has consolidation were analyzed retrospectively, in our Hospital from 2010 to 2016. The total tumor diameter and the volume and diameter of consolidation were analyzed using thin-slice CT and 3D-CT. Preoperative FDG-PET and serum CEA were also measured. Preinvasive lesion and minimally invasive adenocarcinoma were classified as pathologically non-invasive group, and invasive adenocarcinoma was classified as pathologically invasive group. The statistical differences were assessed by the Mann-Whitney U test or chi-square test. We used two machine learning algorithm. Three logistic regression (LR) models were trained based on sex, total tumor diameter, SUVmax, CEA, and (1) consolidation diameter (LR-Cd), (2) consolidation volume (LR-Cv), (3) consolidation diameter and volume (LD-Cd+Cv). Similarly, three random forest (RF) models were trained (RF-Cd, RF-Cv, RF-Cd+Cv). Patients were split into a training set (n = 76) and test set (n = 19). Model performance was measured area under the curve (AUC), and compared using receiver-operating characteristics curve analysis on the test set.
Results
Twenty-six non-invasive adenocarcinomas and 69 invasive adenocarcinomas were evaluated. The consolidation diameter and volume, and SUVmax of invasive group were significantly greater than those of non-invasive group (p < 0.001). On the test set, AUC of LR-Cd, RF-Cd, LR-Cv, RF-Cv, LR-Cd+Cv and RF-Cd+Cv were 0.687, 0.703,0.628, 0.744, 0.628 and 0.744 respectively.
Conclusions
The pathological invasiveness could be predicted by using machine learning algorithm. Especially, higher AUCs were obtained in RF-Cv and RF-Cd+Cv model.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
107P - The efficacy of adjuvant chemotherapy according to the risk classification of recurrence based on the systemic inflammatory markers in patients with colorectal cancer liver metastases
Presenter: Masatsune Shibutani
Session: Poster display session
Resources:
Abstract
108P - Influence of liver metastasis locations on overall survival in patients with colorectal cancer
Presenter: Takayuki Sone
Session: Poster display session
Resources:
Abstract
109P - 18F-FDG PET/CT textural features as predictors of outcomes in patients with primary advanced colorectal cancer
Presenter: Jing Yang
Session: Poster display session
Resources:
Abstract
110P - D3 lymph node dissection may be necessary in clinical stage I right colon cancer
Presenter: Woong Bae Ji
Session: Poster display session
Resources:
Abstract
111P - Is preoperative chemoradiotherapy necessary for all patients with upper rectal cancer: One center retrospective study
Presenter: Jasur Madyarov
Session: Poster display session
Resources:
Abstract
112P - A retrospective analysis of the association between perioperative, post adjuvant carcinoembryonic antigen level and prognosis in stage III colorectal cancer
Presenter: Ryotaro Kozuki
Session: Poster display session
Resources:
Abstract
113P - Dicer contributes to chemoresistance in colorectal cancer via regulating a set of miRNAs and their downstream mRNAs
Presenter: Liang-Yi Hung
Session: Poster display session
Resources:
Abstract
114P - Efficacy and safety of the combination of bevacizumab with raltitrexed-based chemotherapy as second-line therapy in patients with metastatic colorectal cancer (mCRC): An interim analysis of a multicenter phase II trial
Presenter: Jun Zhu
Session: Poster display session
Resources:
Abstract
115P - Expression of Ki-67 as a prognostic factor in patients with colorectal cancer
Presenter: Kuantkan Zhabagin
Session: Poster display session
Resources:
Abstract
116P - Clinical significance and converionrate relevance of RAS genetic mutation analysis for unresectable colorectal liver metastases: A single-center retrospective study
Presenter: Meiling Ji
Session: Poster display session
Resources:
Abstract